Thiol pathways in the regulation of tissue factor prothrombotic activity.

Abstract:

PURPOSE OF REVIEW:The transmembrane protein tissue factor (TF), the initiator of the extrinsic coagulation cascade and a risk factor for thrombotic disease, largely resides on the cell surface in an inactive, encrypted conformation. Whereas TF procoagulant activation, or decryption, is closely associated with the exposure of procoagulant phosphatidylserine in the outer leaflet of cell membranes, thiol pathways and protein disulfide isomerase (PDI) play increasingly recognized roles in regulating TF prothrombotic pathways. RECENT FINDINGS:TF contains a solvent-exposed allosteric disulfide bond that stabilizes the carboxyl-terminal domain involved in ligand interactions with coagulation factors VIIa and X. PDI is a prime candidate to modify the allosteric disulfide by reduction, S-nitrosylation and glutathionation, implicated as regulators of TF procoagulant activity. In-vivo studies localize PDI to sites of thrombus formation and inhibition of PDI attenuates arterial thrombosis. PDI also contributes to the biogenesis of procoagulant microparticles that are released in the context of TF decryption following ATP-mediated activation of the purinergic P2X7 receptor. Genetic deletion of P2X7 signaling attenuates TF and PDI-dependent thrombosis, identifying a new connection between prothrombotic and proinflammatory pathways. SUMMARY:Although the precise biochemical events of TF encryption and decryption require further study, PDI and thiol pathways emerge as important regulators of vascular thrombotic diseases.

journal_name

Curr Opin Hematol

authors

Versteeg HH,Ruf W

doi

10.1097/MOH.0b013e32834981de

subject

Has Abstract

pub_date

2011-09-01 00:00:00

pages

343-8

issue

5

eissn

1065-6251

issn

1531-7048

journal_volume

18

pub_type

杂志文章,评审
  • Zebrafish as a model system for the study of hemostasis and thrombosis.

    abstract:PURPOSE OF REVIEW:Although the zebrafish has been established as a research tool over the past two to three decades, in hematology it has primarily been used to investigate areas distinct from coagulation. The advantages of this vertebrate model include high fecundity, rapid and external development, and conservation o...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0000000000000075

    authors: Weyand AC,Shavit JA

    更新日期:2014-09-01 00:00:00

  • Core binding factor acute myeloid leukemia (CBF-AML): is high-dose Ara-C (HDAC) consolidation as effective as you think?

    abstract:PURPOSE OF REVIEW:Core binding factor acute myeloid leukemia (CBF-AML) corresponds to two distinct subtypes of AML characterized by recurrent favorable chromosome translocations, namely t(8;21) and inv(16)/t(16;16). Given the relatively good outcome of patients with CBF-AML, when treated with intensive chemotherapy inc...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0b013e3283257b18

    authors: Dombret H,Preudhomme C,Boissel N

    更新日期:2009-03-01 00:00:00

  • Human parvovirus B19 infection.

    abstract::Human parvovirus B19 shows remarkable tropism for human erythroid progenitor cells. The pathogenesis of disease resulting from infection is a dynamic between the viral suppression of erythropoiesis and the host's ability to mount an effective immune response. Understanding this process has led to strategies for treati...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/00062752-199603020-00002

    authors: Carper E,Kurtzman GJ

    更新日期:1996-03-01 00:00:00

  • Chronic idiopathic neutropenias and severe congenital neutropenia.

    abstract:PURPOSE OF REVIEW:Chronic idiopathic and severe congenital neutropenias are rare disorders for which recent discoveries have highlighted mechanisms and consequences. RECENT FINDINGS:An inflammatory bone marrow milieu has been shown to be a major contributor to the pathophysiology of chronic idiopathic neutropenia. Act...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0b013e3282f172d3

    authors: Palmblad J,Papadaki HA

    更新日期:2008-01-01 00:00:00

  • Use of stem cell factor to mobilize hematopoietic progenitors.

    abstract::Stem cell factor (SCF) is a multipotent growth factor that plays a role in the growth and development of hematopoietic cells, spermatocytes, melanocytes, and mast cells. SCF alone has little direct stimulatory activity on hematopoietic progenitors but acts synergistically with other colony-stimulating factors to poten...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章

    doi:10.1097/00062752-199704030-00001

    authors: Bearman SI

    更新日期:1997-05-01 00:00:00

  • Immune and idiopathic neutropenia.

    abstract::Neutropenia is often attributed to immunologically mediated injury to mature neutrophils or their precursors. Clinically it is useful to classify immune mediated neutropenias as isoimmune, autoimmune (including some drug-associated neutropenias), and idiopathic (cases possibly with an immune mechanism). Isoimmune neut...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/00062752-199801000-00006

    authors: Dale DC

    更新日期:1998-01-01 00:00:00

  • Role of the polycomb group gene BMI1 in normal and leukemic hematopoietic stem and progenitor cells.

    abstract:PURPOSE OF REVIEW:The polycomb group gene BMI1 fulfills essential roles in both normal and leukemic stem cells. The underlying molecular mechanisms are beginning to become unraveled and an overview of the current knowledge on BMI1 signaling in normal and leukemic stem cells will be presented here. RECENT FINDINGS:In a...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0b013e328338c439

    authors: Schuringa JJ,Vellenga E

    更新日期:2010-07-01 00:00:00

  • Influence of hereditary or acquired thrombophilias on the treatment of venous thromboembolism.

    abstract:PURPOSE OF REVIEW:Deficiency of antithrombin, protein C, and protein S increases the risk of a first venous thromboembolism (VTE) by at least 10-fold and is rare (i.e., <0.5% of population), whereas factor V Leiden and the prothrombin G20210A gene increase this risk by 2-5-fold and are common (2-5% of whites). Antiphos...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0b013e328356745b

    authors: Kearon C

    更新日期:2012-09-01 00:00:00

  • Acute graft-versus-host disease: new treatment strategies.

    abstract:PURPOSE OF REVIEW:Graft-versus-host disease (GVHD) remains a major cause of morbidity and mortality after allogeneic hematopoietic cell transplantation (HCT), despite improvements in our understanding of its pathophysiology as well as the generation of new monoclonal antibodies, immunomodulatory chemotherapy, cellular ...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0b013e3283319a6f

    authors: Paczesny S,Choi SW,Ferrara JL

    更新日期:2009-11-01 00:00:00

  • Recent advances in multiple myeloma.

    abstract::Multiple myeloma is the second most common hematologic malignancy, with approximately 15,000 new cases each year in the United States. Our understanding of the pathophysiology underlying myeloma continues to expand, but the cause of this plasma cell dyscrasia remains unclear. Though controversy remains regarding a pos...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/00062752-200007000-00007

    authors: Sjak-Shie NN,Vescio RA,Berenson JR

    更新日期:2000-07-01 00:00:00

  • Role of FLT3 in leukemia.

    abstract::FLT3 is the most frequently mutated gene in cases of acute myelogenous leukemia (AML). About 30 to 35% of patients have either internal tandem duplications (ITDs) in the juxtamembrane domain or mutations in the activating loop of FLT3. FLT3 mutations occur in a broad spectrum of FAB subtypes in adult and pediatric AML...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/00062752-200207000-00003

    authors: Gilliland DG,Griffin JD

    更新日期:2002-07-01 00:00:00

  • Diagnosis and treatment of cytomegalovirus infection.

    abstract::Cytomegalovirus (CMV) infection remains a major cause of morbidity and mortality in recipients of an allogeneic stem cell transplant (SCT). Due to the broad application of antiviral prophylaxis and preemptive therapy, a decrease in early-onset and a subsequent increase in late-onset CMV disease has been observed. New ...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/00062752-199811000-00022

    authors: Hebart H,Einsele H

    更新日期:1998-11-01 00:00:00

  • Matched sibling donor hematopoietic stem cell transplantation for thalassemia.

    abstract:PURPOSE OF REVIEW:Bone marrow transplantation is the only curative treatment for severe thalassemia. Since its successful first report in 1981, more than 4000 patients with this disease worldwide underwent bone marrow transplantation. The purpose of this review is to update the most recent reports of matched sibling do...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0000000000000286

    authors: Issaragrisil S,Kunacheewa C

    更新日期:2016-11-01 00:00:00

  • Progress in the treatment of adults with acute lymphoblastic leukemia.

    abstract:PURPOSE OF REVIEW:Despite improvements in the achievement of complete remission and progress in the supportive care of adults with acute lymphoblastic leukemia during the last decade, the majority of patients have eventually relapsed with overall survival in adult acute lymphoblastic leukemia of only 30-40%. However, t...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0b013e3283034697

    authors: Larson S,Stock W

    更新日期:2008-07-01 00:00:00

  • Acute chest syndrome and sickle cell disease.

    abstract::Acute chest syndrome (ACS) is the presence of a new pulmonary infiltrate in combination with fever or respiratory symptoms in a patient with sickle cell disease. ACS is the leading cause of death in sickle cell disease, and many patients suffer from multiple, severe episodes. Age has a striking effect on the clinical ...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/00062752-199803000-00002

    authors: Golden C,Styles L,Vichinsky E

    更新日期:1998-03-01 00:00:00

  • Unexpected functions of nuclear factor-κB during germinal center B-cell development: implications for lymphomagenesis.

    abstract:PURPOSE OF REVIEW:B-cell tumors originating from the transformation of germinal center B cells frequently harbor genetic mutations, leading to constitutive activation of the nuclear factor-κB (NF-κB) signaling pathway. The present review highlights recent insights into the roles of separate NF-κB transcription factors ...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0000000000000160

    authors: Klein U,Heise N

    更新日期:2015-07-01 00:00:00

  • Immunotherapy for thrombotic thrombocytopenic purpura.

    abstract:PURPOSE OF REVIEW:This review focuses on recent advances in the use of immune-based therapy to treat patients with refractory and relapsing acquired thrombotic thrombocytopenic purpura. RECENT FINDINGS:Advances in understanding of the pathophysiology of idiopathic thrombotic thrombocytopenic purpura have provided the ...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/01.moh.0000170534.33517.99

    authors: Cataland SR,Wu HM

    更新日期:2005-09-01 00:00:00

  • Is cure for chronic myeloid leukemia possible in the tyrosine kinase inhibitors era?

    abstract:PURPOSE OF REVIEW:The advent of tyrosine kinase inhibitors (TKI) has remarkably changed the treatment of chronic myeloid leukemia (CML). Patients treated in chronic phase can enjoy an expected survival similar to the general population. In the last few years we have found that some patients with an excellent therapeuti...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0000000000000224

    authors: Bansal A,Radich J

    更新日期:2016-03-01 00:00:00

  • Lithium in the treatment of neutropenia.

    abstract:PURPOSE OF REVIEW:The capacity of lithium to induce neutrophilia and increase circulating CD34(+) cells of marrow origin has long been known. Lithium has been the object of hematological investigations for many years, but no definitive use in hematology has yet emerged. RECENT FINDINGS:We review the evidence that lith...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,收录出版,评审

    doi:10.1097/MOH.0b013e32834da93b

    authors: Petrini M,Azzarà A

    更新日期:2012-01-01 00:00:00

  • MicroRNAs in endothelial cell homeostasis and vascular disease.

    abstract:PURPOSE OF REVIEW:Since the first discovery of microRNAs (miRNAs) in 1993, the involvement of miRNAs in different aspects of vascular disease has emerged as an important research field. In this review, we summarize the fundamental roles of miRNAs in controlling endothelial cell functions and their implication with seve...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0000000000000424

    authors: Fernández-Hernando C,Suárez Y

    更新日期:2018-05-01 00:00:00

  • Patent foramen ovale and stroke: what should be done?

    abstract:PURPOSE OF REVIEW:The role of a patent foramen ovale (PFO) as a risk factor for ischemic stroke has been established in recent years. However, the best therapeutic option to prevent recurrent events is still controversial, with antithrombotic treatment or transcatheter PFO closure being favored by different clinicians....

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0b013e32832d47dd

    authors: Di Tullio MR,Homma S

    更新日期:2009-09-01 00:00:00

  • Bone marrow transplantation for globoid cell leukodystrophy, adrenoleukodystrophy, metachromatic leukodystrophy, and Hurler syndrome.

    abstract::Bone marrow transplantation protocols for inherited metabolic storage diseases are unique for each disorder treated. Differences depend also upon how old the patient was when onset occurred and rate of progression of disease. Treatment is directed to prevent or ameliorate the inexorable neurological deterioration that...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/00062752-199911000-00004

    authors: Krivit W,Aubourg P,Shapiro E,Peters C

    更新日期:1999-11-01 00:00:00

  • Endothelial cell biology of Endoglin in hereditary hemorrhagic telangiectasia.

    abstract:PURPOSE OF REVIEW:Mutations in the Endoglin (Eng) gene, an auxiliary receptor in the transforming growth factor beta (TGFβ)-superfamily signaling pathway, are responsible for the human vascular disorder hereditary hemorrhagic telangiectasia (HHT) type 1, characterized in part by blood vessel enlargement. A growing body...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0000000000000419

    authors: Sugden WW,Siekmann AF

    更新日期:2018-05-01 00:00:00

  • Sirtuin 1, stem cells, aging, and stem cell aging.

    abstract:PURPOSE OF REVIEW:New discoveries focused on mitochondrial metabolism and gene silencing and their regulation by the sirtuin family of protein deacetylases is stimulating new ideas on how to improve geriatric medicine. Information about sertuins in stem cell biology is scarce. We consider recent information on sirtuin ...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0b013e3283043819

    authors: Mantel C,Broxmeyer HE

    更新日期:2008-07-01 00:00:00

  • Novel strategies for steroid-refractory acute graft-versus-host disease.

    abstract:PURPOSE OF REVIEW:Graft-versus-host disease is one of the commonest complications of allogeneic bone marrow or peripheral blood stem cell transplantation. This review will cover advances in the pathophysiology of graft-versus-host disease and new agents under investigation for the treatment of this disorder. Patients d...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/01.moh.0000148763.12733.bb

    authors: Bolaños-Meade J,Vogelsang GB

    更新日期:2005-01-01 00:00:00

  • Angiogenesis: vascular remodeling of the extracellular matrix involves metalloproteinases.

    abstract::Endothelial cell invasion is an essential event during angiogenesis (the formation of new blood vessels). This process involves the degradation of the extracellular matrix, the basement membrane, and interstitial stroma, and is governed by the activation of matrix metalloproteinases. However, the contribution of matri...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/00062752-200303000-00007

    authors: Heissig B,Hattori K,Friedrich M,Rafii S,Werb Z

    更新日期:2003-03-01 00:00:00

  • Advances in the immunotherapy of hematologic malignancies: cellular and humoral approaches.

    abstract::Therapy with unconjugated monoclonal antibodies (mAbs) and radiolabeled mAbs has shown activity in patients with B-cell non-Hodgkin's lymphoma and leukemia. Drug-conjugated mAbs are active in relapsed leukemia. Using these new agents with and after chemotherapy induces a high rate of remission, but this needs to be co...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/00062752-199907000-00005

    authors: Maloney DG

    更新日期:1999-07-01 00:00:00

  • New insights into IVIg mechanisms and alternatives in autoimmune and inflammatory diseases.

    abstract:PURPOSE OF REVIEW:Intravenous immunoglobulin (IVIg) is an effective treatment for an increasing number of autoimmune and inflammatory conditions. However, IVIg continues to be limited by problems of potential shortages and cost. A number of mechanisms have been described for IVIg, which have been captured in newly emer...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章

    doi:10.1097/MOH.0000000000000609

    authors: Norris PAA,Kaur G,Lazarus AH

    更新日期:2020-11-01 00:00:00

  • Recent advances in the antiphospholipid antibody syndrome.

    abstract:PURPOSE OF REVIEW:The antiphospholipid syndrome (APS) is a systemic autoimmune disorder characterized by recurrent thrombosis and/or obstetrical morbidity in the presence of persistently positive antiphospholipid antibodies. Recent insights into the pathogenesis of APS have begun to elucidate pathophysiology and led to...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0000000000000067

    authors: Chaturvedi S,McCrae KR

    更新日期:2014-09-01 00:00:00

  • Clinical applications of stem cell factor.

    abstract::Stem cell factor is an early-acting hematopoietic cytokine that probably functions constitutively to support the proliferation and survival of pluripotent progenitor cells and to increase their receptivity to lineage commitment and differentiation in response to lineage-specific cytokines. Stem cell factor also can in...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/00062752-199603030-00010

    authors: Glaspy J

    更新日期:1996-05-01 00:00:00